Učitavanje...

Evaluation of the C6 Lyme Enzyme Immunoassay for the Diagnosis of Lyme Disease in Children and Adolescents

Background. The commercially-available C6 Lyme enzyme immunoassay (EIA) has been approved to replace the standard whole-cell sonicate EIA as a first-tier test for the diagnosis of Lyme disease and has been suggested as a stand-alone diagnostic. However, the C6 EIA has not been extensively studied in...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Izdano u:Clin Infect Dis
Glavni autori: Lipsett, Susan C., Branda, John A., McAdam, Alexander J., Vernacchio, Louis, Gordon, Caroline D., Gordon, Catherine R., Nigrovic, Lise E.
Format: Artigo
Jezik:Inglês
Izdano: Oxford University Press 2016
Teme:
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC5019286/
https://ncbi.nlm.nih.gov/pubmed/27358358
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/cid/ciw427
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!